Organisation paid for research Program year 2021 Source: CMS Open Payments

Medycal Research Inc

Neither a doctor nor a teaching hospital

Research payments

$653,579

48 payments

Through program year 2021, Medycal Research Inc is reported as receiving $653,579 in research payments, across 48 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$17,132	5
2020	Research	$385,926	34
2019	Research	$250,520	9

Breakdown

Who paid Research payments · program years 2019–2021

Intercept Pharmaceuticals, Inc. $598,177 30 payments
Pfizer Inc. $55,402 18 payments

Studies the money was for Research payments · program years 2019–2021

1009742 $582,044 26 payments
A Phase 2B Multicenter Randomized Doubleblind Placebocontrolled Doseranging Study to Evaluate the Efficacy Safety and Pharmacokinetics of Pf06480605 in Adult Participants With Moderate to Severe Ulcerative Colitis $23,504 6 payments
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (REVERSE) $16,132 4 payments
A Phase 3B Randomized Doubleblind Doubledummy Active Controlled Multicenter Study Assessing the Efficacy and Safety of Abrocitinib Compared With Dupilumab in Adult Participants on Background Topical Therapy With Moderate to Severe Atopic Dermatitis $8,503 9 payments
A Phase 2 Randomized Doubleblind Doubledummy Placebocontrolled Doseranging Dosefinding Parallel Group Study to Assess Efficacy and Safety of Pf06865571 Dgat2i Alone and When Coadministered With Pf05221304 Acci in Adult Participants With Biopsyconfirmed Nonalcoholic Steatohepatitis and Fibrosis Stage 2 Or 3 $8,100 1 payment
A Phase 2B Randomized Doubleblind Parallelgroup Placebocontrolled Study With An Open Label Extension to Evaluate the Safety and Efficacy of Pf06826647 in Participants With Moderate to Severe Ulcerative Colitis $8,000 1 payment
An Openlabel Extension Study to Assess the Longterm Safety and Efficacy of Pf04965842 in Adult Patients With Moderatetosevere Atopic Dermatitis $7,295 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.